Aidoc's CARE foundation model won FDA clearance for 11 new CT triage indications, bringing its total to 14, and the company followed with a $150 million Series E that pushed its total funding past $500 million.
ARPA-H is putting $62.7 million behind ADVOCATE, a push to build the first FDA-authorized autonomous AI agent for heart failure care, with Tempus AI, Updoc and Atman Health racing toward a two-year authorization deadline.
India's MeitY Secretary said AI can expand healthcare accessibility and improve diagnosis nationwide, comments reflecting the government's growing emphasis on AI as a tool to address the country's rural doctor shortage.
Utah launched a pilot allowing patients to receive AI-generated prescriptions for topical acne medication without an in-person visit, even as the state's medical board separately moves to suspend a different AI prescribing program over safety concerns.
Mass General Brigham's new AI intake agent inside MyChart routes primary-care patients to appointments, with the health system reporting 77% of users get seen the same day they report a new concern.
Google has replaced the Fitbit app with Google Health, adding a Gemini-powered AI coach that summarizes medical records and answers health questions as wearable makers race to become AI health platforms.
Whoop's $575 million Series G, backed by Abbott and Mayo Clinic, pushes its valuation to $10.1 billion as wearable makers race to reposition continuous health tracking as a clinical, not just fitness, tool.
Northwestern Medicine embedded OpenEvidence's AI clinical guidance directly into its Epic electronic health record, letting physicians check dosing and treatment guidelines without leaving the patient chart.
AstraZeneca signed a deal worth up to $1.5 billion with AI drug discovery startup insitro targeting liver and heart disease, paying just $40 million upfront with the rest tied to development milestones.
The FDA's comment period on a preliminary framework for regulating generative-AI medical devices closes October 19, even as a citizen petition challenges whether such AI tools fall under the agency's jurisdiction at all.